"Extracellular chromatin burden predicts restenosis and survival after transcatheter aortic valve replacement (TAVI)"

Project: Research

Status	Finished
Effective start/end date	23/05/20 → 23/05/21

Deoxyribonuclease is prognostic in patients undergoing transcatheter aortic valve replacement.
Mangold, A., Ondracek, A. S., Hofbauer, T. M., Artner, T., Nechvile, J., Panagiotides, N. G., Mirna, M. (Co-author), Hammerer, M. (Co-author), Fejzic, D. (Co-author), Hoppe, U. (Co-author), Wernly, B. (Co-author), Lauten, A., Alushi, B., Franz, M., Schulze, P. C., Wohlschläger-Krenn, E., Lang, I. M. & Lichtenauer, M. (Last author), 2021, In: EUROPEAN JOURNAL OF CLINICAL INVESTIGATION . 51, 11, p. e13595
Research output: Contribution to journal › Original Article › peer-review

1 Citation (Web of Science)

Project Details